$ 49.77
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Solid dividends
About
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology,...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD
Target Price
The average target price of SNY is 63 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
